These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20300530)

  • 1. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.
    Cestari I; Ramirez MI
    PLoS One; 2010 Mar; 5(3):e9721. PubMed ID: 20300530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential ability to resist to complement lysis and invade host cells mediated by MBL in R4 and 860 strains of Trypanosoma cruzi.
    Evans-Osses I; Mojoli A; Beltrame MH; da Costa DE; DaRocha WD; Velavan TP; de Messias-Reason I; Ramirez MI
    FEBS Lett; 2014 Mar; 588(6):956-61. PubMed ID: 24560788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
    Arroyo-Olarte RD; Martínez I; Cruz-Rivera M; Mendlovic F; Espinoza B
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170332. PubMed ID: 29513875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A; Hieny S; Joiner K
    J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
    Norris KA; Bradt B; Cooper NR; So M
    J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.
    Joiner KA; daSilva WD; Rimoldi MT; Hammer CH; Sher A; Kipnis TL
    J Biol Chem; 1988 Aug; 263(23):11327-35. PubMed ID: 3042767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
    Rimoldi MT; Sher A; Heiny S; Lituchy A; Hammer CH; Joiner K
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):193-7. PubMed ID: 3277170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
    Rimoldi MT; Tartanian A; Joiner KA
    Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host cell invasion and oral infection by Trypanosoma cruzi strains of genetic groups TcI and TcIV from chagasic patients.
    Maeda FY; Clemente TM; Macedo S; Cortez C; Yoshida N
    Parasit Vectors; 2016 Apr; 9():189. PubMed ID: 27038796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
    Norris KA
    Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process.
    Wyllie MP; Ramirez MI
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28859399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N
    Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ramírez-Toloza G; Ferreira A
    Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which Factor H protects
    Menon SS; Ramirez-Toloza G; Wycoff KL; Ehinger S; Shaughnessy J; Ram S; Ferreira VP
    Front Immunol; 2024; 15():1152000. PubMed ID: 38361922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of Trypanosoma cruzi metacyclic trypomastigotes by ion exchange chromatography in sepharose-DEAE, a novel methodology for host-pathogen interaction studies.
    Cruz-Saavedra L; Muñoz M; León C; Patarroyo MA; Arevalo G; Pavia P; Vallejo G; Carranza JC; Ramírez JD
    J Microbiol Methods; 2017 Nov; 142():27-32. PubMed ID: 28865682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
    Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
    J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
    Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
    Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.